WebTalaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune disorders, today reported financial results for the quarter and year ended December 31, 2024, and provided an update on its business. First. WebTalaris Therapeutics Feb 2024 - Present3 months Louisville, Kentucky, United States Regional Talent Acquisition Partner [C] ADESA Oct 2024 - …
Talaris Therapeutics Finalizes $150 Million IPO (Pending:TALS)
WebTalaris Therapeutics, Inc. is a cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and … Web7 Mar 2024 · When is Talaris Therapeutics's earnings date? Talaris Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 16th, 2024 based off last year's report dates. Learn more on TALS's earnings history. bufflo air
Working at Talaris Therapeutics Glassdoor
WebManufacturing (Current Employee) - Louisville, KY - November 19, 2024. I have watched this company grow from a handful of employees to 100+ working in 15+ states. Collectively, our leadership team has a wealth of start up and commercial experience. Staff are encouraged and well supported when wanting to receiving training to grow in their roles ... WebDuring Covid, built Talaris talent 500% at 23 locations across the U.S. including key clinical, medical affairs, operations, and technology hires. … WebTalaris Therapeutics Mar 2024 - Present1 year 2 months Louisville, Kentucky Perform analytical tests including flow cytometry, endotoxin, … cro insect bioassays